Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors

BMC Cancer

Table 4 Cox multivariate survival analysis for T2b and T3 group

Variables	T2b group (n = 869)						T3 group (n = 1081)
	5-year OS			5-year DFS			5-year OS			5-year DFS
	HR	95%CI	P	HR	95%CI	P	HR	95%CI	P	HR	95%CI	P
Age(years)	1.007	0.991–1.024	0.387	0.997	0.984–1.010	0.644	1.004	0.993–1.016	0.464	0.999	0.989–1.009	0.840
Histological type			0.022			0.001			0.035			0.110
Squamous cell carcinoma	1	-	-	1	-	-	1	-	-	1	-	-
Adenocarcinoma	1.999	1.092–3.660	0.025	2.098	1.298–3.392	0.003	1.605	0.851–3.027	1.144	1.405	0.769–2.567	0.269
Adenosquamous cell carcinoma	2.33	0.993–5.817	0.070	1.623	0.711–3.705	0.250	2.733	1.109–6.733	0.029	2.156	0.946–4.916	0.068
initiatreatment modality			0.030			0.003			0.870			0.865
R-CT	1	-	-	1	-	-	1	-	-	1	-	-
ARH	0.490	0.236–1.017	0.056	1.101	0.702–1.725	0.676	0.879	0.281–2.746	0.824	0.747	0.239–2.328	0.614
NACT	1.353	0.901–2.032	0.146	1.847	1.347–2.532	< 0.001	0.780	0.284–2.139	0.629	1.075	0.499–2.316	0.853

ISSN: 1471-2407